Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential effects of 17beta-estradiol and raloxifene on VSMC phenotype and expression of osteoblast-associated proteins.

American journal of physiology. Endocrinology and metabolism - 1 Jul 2005

Rzewuska-Lech Ewa, Jayachandran Muthuvel, Fitzpatrick Lorraine A, Miller Virginia M

Abstract excerpt

Several studies demonstrate an association between osteoporosis and arterial calcific disease, both of which being common in elderly women. Estradiol and raloxifene, a selective estrogen receptor modulator, prevent bone loss in postmenopausal women. Little is known regarding how these agents affect arterial calcification. The aim of this study was to determine whether or not 17beta-estradiol and raloxifene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Differentiation
Share to Cells, Cultured

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estradiol

Share to Extracellular Matrix Proteins

Share to Gene Expression Regulation

Share to Muscle, Smooth, Vascular

Share to Osteoblasts

Source

Identifiers

PMID: 15713688
DOI: 10.1152/ajpendo.00366.2004

Genes

MGP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential effects of 17beta-estradiol and raloxifene on VSMC phenotype and expression of osteoblast-associated proteins.PMID 15713688Read ↗

The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells.Semantic proximity Read ↗

Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.Semantic proximity Read ↗

Estrogen Receptor Control of Atherosclerotic Calcification and Smooth Muscle Cell Osteogenic Differentiation.Semantic proximity Read ↗

Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness.Semantic proximity Read ↗

Cell Phenotype Transitions in Cardiovascular CalcificationSemantic proximity Read ↗

The molecular biology and pathophysiology of vascular calcification.Semantic proximity Read ↗

BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells.Semantic proximity Read ↗

Cyclic strain inhibits switching of smooth muscle cells to an osteoblast-like phenotype.Semantic proximity Read ↗

Bone morphogenetic proteins in vascular calcification.Semantic proximity Read ↗

ECM Modifications Driven by Age and Metabolic Stress Directly Promote Vascular Smooth Muscle Cell Osteogenic Processes.Semantic proximity Read ↗

Vascular smooth muscle cell differentiation to an osteogenic phenotype involves matrix metalloproteinase-2 modulation by homocysteine.Semantic proximity Read ↗

Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.